Vimarsana
Biggest News Aggregation in the World

Page 3 - Cell Type Specific Expression News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Type Specific Expression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Type Specific Expression Today - Breaking & Trending Today

Voyager Therapeutics : Reports Fourth Quarter and Full Year 2021 Financial and Operating Results - Form 8-K - Vimarsana News

Voyager Therapeutics : Reports Fourth Quarter and Full Year 2021 Financial and Operating Results - Form 8-K

Voyager Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results License option agreement with Novartis for target-specific access... | March 8, 2022

Voyager In Deal With Novartis For Target-Specific Access To TRACER AAV Capsids - Vimarsana News

Voyager In Deal With Novartis For Target-Specific Access To TRACER AAV Capsids

BASEL (dpa-AFX) - Voyager Therapeutics, Inc. (VYGR), a developer of adeno-associated virus or AAV capsids, announced Tuesday a license option agreement, under which Novartis (NVS) will receive

Pfizer, Voyager Therapeutics ink USD 630 million gene therapy deal - Vimarsana News

Pfizer, Voyager Therapeutics ink USD 630 million gene therapy deal

Under the terms of the agreement, Pfizer will have the right to evaluate novel capsids selected for central nervous system and cardiac tropisms from Voyager's TRACER platform and to exercise options...

Pfizer and Voyager Agree to Develop Neurologic and Cardiovascular Gene Therapies Valued at up to $630 Million | Rothwell, Figg, Ernst & Manbeck, P.C. - Vimarsana News

Pfizer and Voyager Agree to Develop Neurologic and Cardiovascular Gene Therapies Valued at up to $630 Million | Rothwell, Figg, Ernst & Manbeck, P.C.

On October 6, 2021, Voyager Therapeutics and Pfizer entered into a license option agreement, which allows Pfizer to exercise options to license Voyager’s adeno-associated virus (AAV)...

Voyager Therapeutics (NASDAQ:VYGR) - Voyager CEO Resigns After Company Turns Back To Discovery-Stage - Vimarsana News

Voyager Therapeutics (NASDAQ:VYGR) - Voyager CEO Resigns After Company Turns Back To Discovery-Stage

Voyager Therapeutics, Inc (NASDAQ: VYGR) CEO and President Andre Turenne will step down as the beleaguered company announced it would move ...